Ledger.Open graph →
SEC Form D · filed August 28, 2020

SignPath Pharma, Inc

Offering
$10.0M
Sold
$525K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Sandy, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Peter P. Sordillo · Sandy, UTExecKai Larson · Sandy, UTExec · DirectorRobert P. Seguso · Sandy, UTExec · DirectorKenneth S. Kranzberg · New York, NYExec · DirectorArash Soheili · Kensington, MDExecJeffrey Rosengarten · Northbrook, ILExec · DirectorTimothy P. Toloukian · Sandy, UTExecArthur P. Bollon, Ph.D · Quakertown, PADirectorLouis Laskis · TEMPE, AZExec · DirectorShawn R. Jenkins · CHARLESTON, SCExec · DirectorDonald R. Taylor · CHARLESTON, SCExecTimothy P. Toloukian · Sandy, UTExecArthur P. Bollon, Ph.D · Quakertown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗